Amphastar Pharmaceuticals (AMPH) PT Lowered to $30 at Wells Fargo
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $22.01 +0.59%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Wells Fargo analyst Benjamin Burnett lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $30.00 (from $34.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Downgrades Workday (WDAY) to Hold
- Donaldson Company (DCI) PT Raised to $95 at Stifel
- Nomura/Instinet Upgrades Malayan Banking Bhd (MAY:MK) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
